Delivery Order SPE2DB22D2108-SPE2DB24FU4WE

Award Date 9/10/24
Potential Completion Date 9/11/24
Potential Value $2.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,331.76 firm fixed-price delivery order is for the supply of Oxycontin ER 30 mg tablets. The contract has an ultimate completion date of April 2, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $1,079.46 firm fixed-price delivery order is for the supply of Oxycontin ER 30 mg tablets. The contract has an ultimate completion date of June 5, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive global...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The delivery order is for the supply of OxyContin ER 10 mg tablets, valued at $1,301.86 and has a period of performance through March 18, 2024. Amerisourcebergen Drug Corp is the prime contractor on a larger indefinite delivery contract (IDC) with DLA Troop Support Medical valued at up...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,998.37, is for the supply of Oxycontin ER 20 mg tablets. The award has an ultimate completion date of January 22, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,602.62 firm fixed price delivery order is for the supply of Oxycontin ER 30 mg tablets. The contract has a June 2025 completion date and is not set aside. AmerisourceBergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,770.21 firm fixed-price delivery order is for the supply of 100-count bottles of the prescription drug OxyContin ER 30 mg tablets. This award is part of Amerisourcebergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. That single-award IDC...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $1,882.50 delivery order is for the supply of OxyContin ER 40 mg tablets. This delivery order falls under a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00, which serves as the primary contract vehicle for Amerisourcebergen Drug...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $6,319.02 to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the supply of 4,565,735 units of OxyContin ER 40 mg tablets, with a period of performance through September 10, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to $999,999,999 and running through...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,220.69, is for the supply of Oxycontin ER 20 mg tablets. The contract has an ultimate completion date of March 17, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,190.96 fixed-price contract is for the delivery of 4,567,372,844 units of Oxycontin ER 30 mg tablets, with a completion date of February 26, 2025. The award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through...
  • SPE2DB22D2108
    Indefinite Delivery Contract
  • SPE2DB22D2108-SPE2DB24FU4WE
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to the pharmaceutical distributor AmerisourceBergen Drug Corporation for the supply of OxyContin ER 30 mg tablets. The contract award is valued at $2,086.80 and has an ultimate completion date of September 11, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which is valued at up to $999,999,999 through December 2025 for the provision of a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 12/10/24, 2:16 PM